Pulmonary Hypertension Due to Left Heart Disease
📧 Sign up to get email alerts when something new happens for Pulmonary Hypertension Due to Left Heart Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Evaluation of the BMPR2-Activin Signaling Pathway in Group II Pulmonary Hypertension.
A recruiting clinical trial at Hospital General Universitario Gregorio Marañon is evaluating the BMPR2-Activin signaling pathway in Group II…
-
CLINICAL_TRIALS research · 2025-08-01Clinical Trial Update: Pulmonary Hypertension Biorepository and Registry
A pulmonary hypertension biorepository and registry sponsored by the University of Kansas Medical Center is actively recruiting (NCT04808596…
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: A Study to Learn How Safe the Study Treatment BAY2701250 is, How it Affects the Body and How it Moves Into, Through and Out of the Body in Healthy Male Participants When a Single Amount is Given as an Injection Into the Vein (Intravenous Infusion) or Under the Skin (Subcutaneous Injection) [Phase 1]
Phase 1 study assessing safety, pharmacokinetics, and body disposition of BAY2701250 given by IV or subcutaneous injection in healthy male p…
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: Inhaled and Intravenous Milrinone in Patients With Severe Pulmonary Hypertension [Phase 4]
A Phase 4 clinical trial is evaluating inhaled and intravenous milrinone in patients with severe pulmonary hypertension due to left heart di…
-
CLINICAL_TRIALS research · 2017-06-14Clinical Trial Update: Registry for Pulmonary Hypertension Due to Left Heart Disease in China
A Chinese clinical trial registry update documents a registry study on pulmonary hypertension caused by left heart disease, sponsored by the…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.